AstraZeneca PLC AZN shares slid 3.89% to £128.34 Friday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.24% to 10,497.29.

Sino Biopharmaceutical Limited expanded its strategic partnership with GSK Plc GSK and separately signed an exclusive ...

The damage to AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) from Wainua's trial failure is less about the numbers than about a dent ...

AstraZeneca Plc suffered a rare setback in a trial of a new heart drug, surprising investors used to positive results from the UK drugmaker and sending its shares down almost 10%.Most Read from Bloomb ...

Ionis Pharmaceuticals Inc. IONS and partner AstraZeneca Plc AZN said on Thursday that their Phase 3 CARDIO-TTRansform study ...

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 9.55% in early trading, wiping £19 billion from the company's valuation, after its Wainua drug failed a closely watched Phase III trial in a form of ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

June 2026Datroway recommended for approval in the EU by CHMP as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy Recommendation ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Discusses Progress in Sustainability Strategy and the Role of AI in Healthcare Innovation July 6, 2026 9:30 AM ...

The pharmaceutical giant is plowing billions of dollars into expanding its drug-making capacity. It has ambitious plans for two facilities in Maryland. 10 stocks we like better than AstraZeneca Plc › ...

June 2026 Enhertu approved in the EU as first tumour agnostic HER2-directed therapy and antibody drug conjugate for patients with previously treated HER2-positive metastatic solid tumours Based on ...